Oct 24, 2016 Cellectar Biosciences Announces Data on CLR 131 Accepted For Poster Presentation at the 58th Annual American Society of Hematology Meeting & Exposition Learn More
Oct 11, 2016 Cellectar Biosciences To Present at SeeThru Equity and Dawson James Investor Conferences Learn More
Oct 6, 2016 Cellectar Biosciences Announces Enrollment of First Patient into Third Cohort of Its Phase I Clinical Study of CLR 131 in Multiple Myeloma Learn More